Skip to content

Clinical Study on TCM Syndrome and Risk Factor Analysis of Postoperative Chemotherapy Patients with Colorectal Cancer

Clinical Study on TCM Syndrome and Risk Factor Analysis of Postoperative Chemotherapy Patients with Colorectal Cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2025001831
Enrollment
Unknown
Registered
2025-09-24
Start date
2025-04-07
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer

Interventions

observation group:NO

Sponsors

Shuguang Hospital Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 3.1 Stage II-IV colorectal cancer with definite pathological and cytological diagnosis; 3.2 Patients receiving chemotherapy regimens; 3.3 Age: 18-75 years, patients with an estimated survival of>6 months; 3.4 KPS =60 points; 3.5 Patients who have undergone surgery 3.6 Voluntary participation and signing of informed consent.

Exclusion criteria

Exclusion criteria: 4.1 Those who are participating in or have participated in clinical trials of other drugs within 4 weeks; 4.2 Pregnant and lactating women 4.3 Evidence of severe or uncontrolled systemic disease (e.g., unstable or uncompensated respiratory, cardiac, hepatic or renal disease) or psychiatric disorders.

Design outcomes

Primary

MeasureTime frame
TCM Syndrome Evaluation Scale;

Secondary

MeasureTime frame
Complete Blood Count;Comprehensive Metabolic Panel;Routine coagulation tests;European Organisation for Research and Treatment of Cancer;Chalder's Fatigue Scale;Athens Insomnia Scale;KarnofskyPerformance Status;Patient Health Questionnaire-9;Generalized anxiety disorder-7;Research on conceptual framework of PRO scale in spleen Qi deficiency syndrome;

Countries

China

Contacts

Public Contactbiling

Shuguang Hospital Shanghai University of Traditional Chinese Medicine

fernazy@126.com13917843775

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026